Disposable articulated spacing device for surgical treatment of joints of the human body

A disposable articulated spacing device for the treatment of joints of the human body, particularly for temporarily replacing an explanted joint prosthesis, comprises at least one first member able to be secured to a first articulation end and at least one second member able to be secured to the other articulation end, both said members being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products. The pre-formed members are reciprocally coupled in an articulated manner to maintain a suitable joint space and at least a partial articulation for the time necessary to perform the further implantation of a joint prosthesis. The biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof. The articulated spacing device maintains a suitable space in the joint seat while allowing considerable articulated mobility, and re-establishes suitable conditions of implantation of a new permanent joint prosthesis.

Skip to: Description  ·  Claims  · Patent History  ·  Patent History
Description
DESCRIPTION

[0001] 1. Technical field

[0002] The present invention is generally applicable to surgical treatment of articulations of the human body and in particular relates to a disposable spacing device for temporary replacement of joint prosthesis which have to be explanted due to unsuccessful septic or aseptic implantation of artificial joints.

[0003] According to the well known surgical “dual stage” method, the above spacing device can be maintained in the joint seat as long as necessary for reestablishing the most favourable conditions of implantation of the new artificial joint prosthesis.

[0004] 2. Background art

[0005] It is known how artificial joints, such as knee, hip, heel and elbow joints often have to be removed for various reasons and mainly following local infections after a surgical implant.

[0006] In such a case, it is not possible to replace immediately the unsuccessful prosthesis with a new one, but the seat of the joint must be treated with suitable antibiotics before a new surgical operation can be performed.

[0007] In the meantime, the space within the joint must be maintained in order to prevent a reduction in the articular space, retraction of-tie tissues, atrophying of the joint and loss of muscular elasticity and tone.

[0008] Spacing devices used in the two-stage implant of artificial joints, for treatment of both the hip and the knee, are known.

[0009] Italian patent application No. VR95A000072 describes a disposable spacing device for an artificial hip joint, essentially characterized in that it is made of a biocompatible base material of the type used for bone cements.

[0010] Spacing devices for knee joints which are manually made by the surgeon at the time of the surgical operation are also known, these devices being made from blocks of bone cement of standard shape, optionally containing active constituents.

[0011] A drawback of these known methods of treatment is that they do not allow the space within the joint to be kept apart in an ergonomically and anatomically correct manner. Moreover, the long time required for preparation increases the difficulties for the surgeon and reduces the probability of success of the operation.

[0012] In order to overcome these drawbacks, spacing devices have been made using suitable anatomically and ergonomically shaped moulds which are filled with bone cement in situ. However, these known spacing devices do not allow mobilisation of the joint and result in the need for a long rehabilitation after reimplanting the permanent prosthesis.

[0013] In still other cases, the spacing devices have been obtained by lining a permanent metal prosthesis with bone cement. Although this solution allows a temporary articulation, it is difficult to prepare and in spite of use of cement-lined prostheses requires that such devices are positioned in infected seats, which most of the surgeon consider a worsening infection factor.

[0014] DE-A-29703971 discloses a temporary knee prosthesis comprising three pre-formed members made of bone cement and impregnated with an antibiotic agent, in accordance with the preamble of claim 1. However, in this prior temporary prosthesis the antibiotic agent is added to the bone cement forming the members during their formation process and therefore the pre-formed members are initially impregnated with such medicaments. Thus, the surgeon has no freedom to choose the specific antibiotic or its amount which are more closely correlated to the particular patient. Moreover, the prosthesis which is not a pharmaceutical product must nevertheless be packaged and stored in a suitable manner to comply with the requirements of the parmaceutical products.

[0015] U.S. Pat. No. 5,980,573 relates to a temporary hip prosthesis comprising a single pre-formed member failing to provide a complete articulation joint. The base material of the prosthesis is impregnated with an antibiotic agent by simply-mixing it in appropriate amount with the constituent elements of the material during the formation process of the member. Although this prior art document provides that the impregnation of the porous temporary prosthesis may be carried out by soaking it in a liquid antibiotic, it contains no indication that the impregnation may be carried out immediately prior of the implantation of the prosthesis. In both cases, the pre-formed temporary prosthesis is pre-packaged in a sterile packet or container having indicia or colour coding indicating the size of the prosthesis contained therein and the antibiotic concentration, thereby excluding that impregnation is accomplished immediately prior of implantation.

[0016] EP-A-0811359 teaches a method for manufacturing a material adapted for use as base material for prostheses, which material is formed by a three dimensional structure of band pieces joined together with the interposition of intermediate removable materials to form adjustable hollow spaces. The hollow spaces of the material may be filled with pharmaceutical or therapeutical active products such as antibiotics, hormones or growing agents. However, there is no indication that such active products may be added or absorbed in the hollow spaces immediately prior of implantation of the prosthesis.

DISCLOSURE OF THE INVENTION

[0017] The main object of the present invention is to provide surgeons with a disposable and ready-to-use articulated spacing device, able to be directly implanted in the articulation seat for example of knee, hip, hell or elbow joints, in case of replacement of a pre-existing prosthesis which must be removed due to septic or aseptic failures.

[0018] A further object is to provide a disposable articulated spacing device which allows to maintain a in a healing environment a suitable articular space for the time necessary to successfully re-implant a new permanent prosthesis.

[0019] A further object is to provide a disposable articulated spacing device which allows correct articulation and an anatomical and ergonomic form of the temporary implant.

[0020] Yet another object is to provide a disposable articulated spacing device which can be easily implanted and explanted into/from the location of the joint.

[0021] Yet another object is to provide a disposable articulated spacing device with limited articular friction so as to allow considerable mobility of the joint and improve the quality of life of the patient during hospitalisation.

[0022] These and other objects which will be more apparent hereinafter are achieved by a disposable articulated spacing device for the temporary replacement of a joint of the human body which, in accordance with claim 1, comprises at least one first member able to be secured to a first articulation end and at least one second member able to be secured to a second a articulation end, both said members being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products, said pre-formed members being able to be reciprocally coupled in an articulated manner to maintain a suitable joint space and at least partial articulated mobility for the time necessary to perform the further implantation of a new permanent joint prosthesis, characterized in that said pre-formed members are initially free of pharmaceutical and therapeutical products, said pre-formed members having a porosity in their base material or suitable cavities formed on their outer surfaces adapted to be filled with pharmaceutical and therapeutical products in the form of liquid solutions added to the pre-formed members immediately prior of implantation thereof either by direct contact and absorption or by insertion thereof in said suitable cavities

[0023] Preferably, the above mentioned biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof.

[0024] The pre-formed members of the device may be previously charged with suitable pharmaceutical and therapeutical products. As alternative, the pre-formed members are initially free of the same products and are added immediately prior of their implantation by contact absorption or by filling of suitable cavities formed on their other surface.

[0025] Advantageously, the pharmaceutical and therapeutical products may be chosen among medical active principles, antibiotics and radiopacifier and may be added in the pre-formed members

[0026] In case that the articulated spacing device replaces a knee joint, the pre-formed members may comprise a femoral member consisting of a body substantially shell-shaped and reproducing the femoral condyles, and tibial members consisting of a prismatic body able to replace the resected tibial flat portion.

BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Further features and advantages of the invention will be more clearly understood in the light of the following detailed description of a disposable articulated spacing device furnished by way of a non-limiting example with the aid of the accompanying drawings, in which:

[0028] FIG. 1 shows a front view of a first detail of a spacing model according to the invention;

[0029] FIG. 2 shows a side view of the detail according to FIG. 1;

[0030] FIG. 3 shows a top view of the detail according to FIG. 1;

[0031] FIG. 4 shows a front view of another detail of the spacing device according to the invention;

[0032] FIG. 5 shows a side view of the detail according to FIG. 4;

[0033] FIG. 6 shows a top view of the detail according to FIG. 4;

[0034] FIGS. 7 and 8 show perspective views, from the top and bottom, of the detail of the device illustrated in FIGS. 1 to 3;

[0035] FIGS. 9 and 10 show a side view and a top perspective view of the detail according to FIGS. 4 to 6;

[0036] FIG. 11 shows a perspective view of the two details of the preceding figures in aligned positions; and

[0037] FIG. 12 shows a side view of an alternative embodiment of the spacing device according to the invention.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

[0038] With reference to the above mentioned figures, there is shown a disposable articulated spacing device for the temporary replacement of a joint prosthesis explanted from a human body.

[0039] The articulated spacing device, generally indicated with the reference number 1, comprises at least one first member 2 able to be secured to a first joint end and at last one second member 3 able to be secured to a second joint end.

[0040] According to the invention, both members 2, 3 are pre-formed and entirely made of a biological compatible and porous material and are mutually coupled in an articulated manner so as to maintain in a healing environment a suitable joint space and at least partial mobility of the joint for the time necessary to permit the further re-implantation of a new permanent joint prosthesis.

[0041] Preferably, the biological compatible and porous material may be chosen among metals, metallic alloys organo-metals, ceramics, glasses, plastics materials and combinations thereof.

[0042] Specifically, the above plastics material may be chosen among thermoplastic polymers, such as acrylic resins, polyethylene, polypropylene, thermoformable e.g. by blow moulding or injection moulding.

[0043] As alternative, the plastics material may be chosen among cold-formable resins curable by means of free radical polymerisation such as acrylic resins and polyesters.

[0044] In a per se known manner, free radical polymerisation may be accelerated either by suitable chemical catalysts and initiators, such as benzoyl peroxide, or physical accelerators such as ionizing radiation, gamma-rays, UV-rays.

[0045] In the particularly preferred embodiment the biological compatible and porous material forming the members 2, 3 is a bone-cements, e.g. that used in the Italian patent application no. VR95A000072 filed by the same applicant.

[0046] The pre-formed members 2, 3 may be previously added with suitable pharmaceutical and therapeutical products chosen among active medical principles, antibiotics and radiopacifiers.

[0047] In alternative, the pharmaceutical and therapeutical products may be added to the pre-formed members immediately prior of implantation thereof either by direct contact absorption or by filling of suitable cavities formed on their outer surfaces.

[0048] The pharmaceutical and therapeutical products in the form of liquid solutions may be easily absorbed by the device thanks to the porosity of their basic material and then released after implantation in the joint seat.

[0049] Advantageously, the pre-formed members 2, 3 may be shaped in different sizes to be correctly adapted to the different patients. Moreover, these members may present anchoring means for their fixation to the joint ends.

[0050] The embodiment of the spacer device 1 shown in the figures is designed to be inserted in the knee joint.

[0051] The pre-formed member 2 is a tibial member and the pre-formed member 3 is a femoral member.

[0052] In particular, the femoral part 3 consists of a first proximal body 4 designed to occupy the space left by an explanted metal prosthesis. Preferably, the body 4 has a shape, in plan view, approximately in the form of a “U” or horseshoe, with side portions 4′, 4″ and a central recess 5. The external contact surface 6 of the body 4 has a curvature able to reproduce that of the femoral condyles.

[0053] The tibial member 2 consists of a second proximal body 7 which is approximately prismatic, slightly curved and of suitable thickness. The body 7 also has a shape, in plan view, approximately in the form of a “U” or horseshoe, with a curved internal contact surface 8 and an internal recess 9 so as to simulate the resected tibial flat portion.

[0054] The contact surfaces 6, 8 of members 2, 3 are formed so as to allow a roto-translatory movement during the flexing/extending movement of the limb.

[0055] Moreover, the surfaces 6, 8 may have an excellent surface finish with a low coefficient of friction so as to allow a considerably degree of articular mobility.

[0056] Both members 2, 3 may be provided with respective projections or rod-shaped distal portions 10, 11 for securing to the respective joint ends, e.g. by means of bone cement.

[0057] In use, the surgeon initially removes the previous infected joint prosthesis and cleans the articulation space. The surgeon further chooses the suitable spacing device with pre-formed members 2, 3 adapted of the size of the patient.

[0058] If the pre-formed members are already previously charged with active principles and pharmaceutical and therapeutical products upon formation thereof, the surgeon implants them taking care that they are fixedly secured to the joint ends and are mutually articulately coupled to allow at least partial mobilisation of the joint.

[0059] If on the contrary the members are not yet charged as above, the surgeon either impinges them in a solution of active principles or fills with them several outer cavities formed in situ or pre-shaped on their outer surfaces, and finally implants the members in the articulation seat, securing them to the joint ends through appropriate anchoring means or bone cement.

Claims

1. A disposable articulated spacing device for the treatment of joints of the human body, particularly for temporary replacing an explanted permanent joint prosthesis, comprising at least one first member (2) able to be secured to a first articulation end and at least one second member (3) able to be secured to a second a articulation end, both said members (2,3) being pre-formed and made entirely of biological compatible and porous material suitable to be added with pharmaceutical and therapeutical products, said pre-formed members (2, 3) being able to be reciprocally coupled in an articulated manner to maintain a suitable joint space and at least partial articulated mobility for the time necessary to perform the further implantation of a new permanent joint prosthesis, characterized in that said pre-formed members (2,3) are initially free of pharmaceutical and therapeutical products, said pre-formed members (2, 3) having a porosity in their base material or suitable cavities formed on their outer surfaces adapted to be filled with pharmaceutical and therapeutical products in the form of liquid solutions added to the pre-formed members (2, 3) immediately prior of implantation thereof either by direct contact and absorption or by insertion thereof in said suitable cavities.

2. Spacing device according to claim 1, characterized in that said biologically compatible and porous material is chosen among metals, metallic alloys, organo-metals, ceramics, glasses, plastics materials, bone cements and combinations thereof.

3. Spacing device according to claim 2, characterized in that said plastics material may be chosen among thermoplastic polymers, such as acrylic resins, polyethylene, polypropylene, thermoformable e.g. by blow moulding or injection moulding.

4. Spacing device according to claim 2, characterized in that plastics material are chosen among cold-formable resins.

5. Spacing device according to claim 1, characterized in that said biological compatible and porous material is a bone cement.

6. Spacing device according to claim 1, characterized in that said pharmaceutical and therapeutical products are chosen among active medical principals, antibiotics and radiopacifiers.

7. Spacing device according to claim 1, characterized in that said pre-formed members (2, 3) are configured so as to allow a roto-translatory movement of the condyles during the flexing/extending movement of the limb.

8. Spacing device according to claim 7, characterized in that said pre-formed members (2, 3) have respective contact surfaces (8, 6) with a minimum coefficient of friction so as to allow a high degree of articular mobility.

9. Spacing device according to one or more of the preceding claims, characterized in that said pre-formed members (2, 3) are shaped in different sizes to be adapted to any patients.

10. Spacing device according to claim 1, characterized in that said pre-formed members (2, 3) are provided with anchoring means for attachment thereof to the joint ends.

11. Spacing device according to claim 10, characterized in that said anchoring means consist of respective projections or rod-shaped distal portions (10, 11).

12. Spacing device according to claim 1, characterized in that said pre-formed members (2, 3) are securable to said joint ends with bone cement.

13. Spacing device according to one or more of the preceding claims, particularly for knee joint, characterized in that said pre-formed members (2, 3) comprises a femoral member (3) and a tibial member (2).

14. Spacing device according to claim 13, characterized in that said femoral member (3) consists of a first body (4) substantially in the shape of a shell to reproduce femoral condyles and that said tibial member (2) consists of a second body (7) of substantially prismatic shape with predetermined thickness to replace the resected tibial flat portion.

Patent History
Publication number: 20040054417
Type: Application
Filed: Feb 5, 2003
Publication Date: Mar 18, 2004
Inventors: Renzo Soffiati (Nogara), Claudio Castelli (Bergamo), Giovanni Faccioli (Monzambano)
Application Number: 10239813
Classifications